Cybin Shares Up Slightly as HELP Backers Focus on Main Trial
Cybin Inc., which trades as Helus Pharma, ticked up Friday. HELP shares on Nasdaq were last seen at $4.55, up 6 cents, or 1.3%. The stock moved between $4.42 and $4.58. Around 385,000 shares traded. Helus Pharma shares barely budged in light trading. With nothing new since the April 30 update on the investor page, the stock traded off sector interest and speculation around the company’s next move instead of reacting to a Friday headline.